Pure Global

RIPC and Platelet Activation on Platelet Activation During Cardiopulmonary Bypass - Trial NCT03458351

Access comprehensive clinical trial information for NCT03458351 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Hospital and is currently Completed. The study focuses on Platelet Dysfunction. Target enrollment is 58 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03458351
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03458351
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
RIPC and Platelet Activation on Platelet Activation During Cardiopulmonary Bypass
Effect of Remote Ischemic Preconditioning on Platelet Activation During Cardiac Surgery With Cardiopulmonary Bypass

Study Focus

Platelet Dysfunction

Remote ischemic preconditioning

Interventional

device

Sponsor & Location

Seoul National University Hospital

Seoul, South Korea

Timeline & Enrollment

N/A

Mar 28, 2018

Aug 14, 2019

58 participants

Primary Outcome

Platelet activation measured by CD62P expression using flow cytometry

Summary

In this study, the investigators are going to investigate the effects of remote ischemic
 preconditioning on platelet activation in patients undergoing cardiac surgery with
 cardiopulmonary bypass.

ICD-10 Classifications

Qualitative platelet defects
Antithrombotic drugs [platelet-aggregation inhibitors]
Essential (haemorrhagic) thrombocythaemia
Other thrombophilia
Haemorrhagic disorder due to circulating anticoagulants

Data Source

ClinicalTrials.gov

NCT03458351

Device Trial